Healthpeak Properties, Inc. (DOC)
3 REITs to Buy for Passive Income in July
Income investors entering July 2026 are getting a friendlier setup than they had six months ago.
Healthpeak Properties Gains 28% in 3 Months: Will the Trend Last?
DOC surges 28% in three months as leasing, occupancy gains and Janus Living growth support its shift toward labs and outpatient assets.
Healthpeak Properties: This 6% Yielding REIT Has More Room To Run
Healthpeak Properties remains a Strong Buy, combining value, income, and recovery potential in healthcare real estate. DOC's outpatient medical and life sciences segments show improving occupancy, strong lease spreads, and embedded rent escalators supporting steady growth. The Janus Living spin-off unlocks value in senior housing, with DOC retaining 82% ownership and benefiting from high segment growth.
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound?
Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?
Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?
DOC gains 22.7% year-to-date, driven by leasing momentum, rising occupancy and Janus Living growth.
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns
Healthpeak Properties earns a buy rating, driven by strong capital allocation and a compelling portfolio mix across Outpatient Medical, Labs, and Senior Housing. DOC trades at ~11x P/FFO with a >6% dividend yield, offering both stability and upside from secular and cyclical trends in its segments. Recent moves—like the Janus Living IPO, opportunistic acquisitions, and disciplined share buybacks—unlock value and enhance capital efficiency.
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity
Healthpeak Properties is still a Buy after the recent rally, supported by strong earnings, a robust dividend, and significant re-rating potential. DOC's Q1 2026 beat on FFO and revenue; completed the Janus Living IPO; and executed major acquisitions, reinforcing portfolio value and future growth prospects. With $1.17 billion in cash and a sustainable 6.2% monthly dividend yield (~70.7% payout ratio), DOC's dividend looks safe despite macroeconomic headwinds, leaving room for more buybacks.
Healthpeak Properties Q1 Earnings Call Highlights
Healthpeak Properties NYSE: DOC reported first-quarter 2026 adjusted funds from operations of $0.45 per share and raised its full-year FFO adjusted guidance after completing several major capital allocation moves, including the IPO of its senior housing business, a joint venture recapitalization with Blackstone and a $100 million stock repurchase.
Healthpeak Properties, Inc. (DOC) Q1 2026 Earnings Call Transcript
Healthpeak Properties, Inc. (DOC) Q1 2026 Earnings Call Transcript
Healthpeak (DOC) Q1 FFO and Revenues Surpass Estimates
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.45 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to FFO of $0.46 per share a year ago.
Key Reasons to Add Healthpeak Properties Stock to Your Portfolio Now
DOC gains from strong lab demand and rising senior healthcare needs, supported by portfolio repositioning and solid balance sheet strength.
Want $5,790 in Passive Income? Invest $30,000 Each Into These 3 High-Yield Dividend Stocks
High-yield dividend stocks offer cash flow with full liquidity, meaning you can add, trim, or exit a position on any trading day.
